Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyotrophic Lateral Sclerosis | 25 | 2023 | 1414 | 3.440 |
Why?
|
Motor Neuron Disease | 4 | 2022 | 99 | 1.080 |
Why?
|
Creatine | 1 | 2019 | 421 | 0.600 |
Why?
|
Hydroxymethylglutaryl CoA Reductases | 1 | 2015 | 58 | 0.510 |
Why?
|
Tamoxifen | 1 | 2019 | 981 | 0.500 |
Why?
|
Carbon Radioisotopes | 4 | 2020 | 577 | 0.380 |
Why?
|
Taurochenodeoxycholic Acid | 2 | 2020 | 34 | 0.380 |
Why?
|
Muscular Diseases | 1 | 2015 | 556 | 0.370 |
Why?
|
Phenylbutyrates | 2 | 2020 | 69 | 0.370 |
Why?
|
Autoimmune Diseases | 2 | 2022 | 2133 | 0.310 |
Why?
|
Acetamides | 2 | 2020 | 249 | 0.300 |
Why?
|
Motor Neurons | 3 | 2021 | 844 | 0.290 |
Why?
|
Pyridines | 3 | 2021 | 2825 | 0.230 |
Why?
|
Receptors, GABA | 3 | 2020 | 288 | 0.230 |
Why?
|
Electromyography | 2 | 2018 | 1379 | 0.210 |
Why?
|
Neurodegenerative Diseases | 2 | 2022 | 1061 | 0.210 |
Why?
|
Positron-Emission Tomography | 6 | 2020 | 6234 | 0.200 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 4931 | 0.200 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2022 | 265 | 0.180 |
Why?
|
Oligonucleotides, Antisense | 1 | 2022 | 433 | 0.180 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3255 | 0.180 |
Why?
|
Spastic Paraplegia, Hereditary | 1 | 2021 | 157 | 0.160 |
Why?
|
Recruitment, Neurophysiological | 1 | 2018 | 32 | 0.160 |
Why?
|
Muscle Strength | 2 | 2019 | 592 | 0.160 |
Why?
|
Videoconferencing | 1 | 2019 | 195 | 0.150 |
Why?
|
Fluorine Radioisotopes | 1 | 2020 | 442 | 0.140 |
Why?
|
Vital Capacity | 1 | 2019 | 925 | 0.140 |
Why?
|
Running | 1 | 2021 | 480 | 0.140 |
Why?
|
Double-Blind Method | 5 | 2022 | 12026 | 0.140 |
Why?
|
Lumbosacral Region | 1 | 2017 | 310 | 0.130 |
Why?
|
Histone Deacetylases | 1 | 2019 | 728 | 0.120 |
Why?
|
Neuroprotective Agents | 1 | 2020 | 941 | 0.120 |
Why?
|
Autoantibodies | 1 | 2022 | 2035 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2021 | 3760 | 0.110 |
Why?
|
Lower Extremity | 1 | 2021 | 1158 | 0.110 |
Why?
|
Neuroglia | 1 | 2017 | 927 | 0.100 |
Why?
|
Motor Cortex | 1 | 2019 | 986 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1790 | 0.100 |
Why?
|
Extremities | 1 | 2017 | 865 | 0.100 |
Why?
|
Brain | 6 | 2021 | 26385 | 0.100 |
Why?
|
Spinal Cord | 1 | 2019 | 1809 | 0.100 |
Why?
|
Humans | 29 | 2023 | 744343 | 0.100 |
Why?
|
Pyrimidines | 2 | 2020 | 2942 | 0.090 |
Why?
|
Necrosis | 1 | 2015 | 1643 | 0.090 |
Why?
|
Pyrazoles | 1 | 2020 | 1972 | 0.090 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3778 | 0.090 |
Why?
|
Cohort Studies | 4 | 2021 | 40561 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2282 | 0.080 |
Why?
|
Aged | 12 | 2022 | 163280 | 0.080 |
Why?
|
Diffusion Tensor Imaging | 1 | 2018 | 2305 | 0.080 |
Why?
|
Middle Aged | 13 | 2021 | 213383 | 0.070 |
Why?
|
Adult | 12 | 2022 | 214055 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7322 | 0.070 |
Why?
|
Immunotherapy | 1 | 2022 | 4445 | 0.070 |
Why?
|
Male | 15 | 2022 | 350118 | 0.060 |
Why?
|
Disease Progression | 4 | 2022 | 13284 | 0.060 |
Why?
|
Linoleic Acids | 1 | 2022 | 39 | 0.050 |
Why?
|
Female | 13 | 2021 | 380194 | 0.050 |
Why?
|
Young Adult | 5 | 2021 | 56430 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2022 | 35421 | 0.050 |
Why?
|
Injections, Spinal | 1 | 2022 | 303 | 0.050 |
Why?
|
Telemedicine | 1 | 2019 | 2872 | 0.050 |
Why?
|
Esters | 1 | 2022 | 210 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57776 | 0.050 |
Why?
|
Neurofilament Proteins | 1 | 2022 | 318 | 0.050 |
Why?
|
Gait Disorders, Neurologic | 1 | 2022 | 231 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 426 | 0.040 |
Why?
|
Time | 1 | 2020 | 542 | 0.040 |
Why?
|
Sick Leave | 1 | 2019 | 110 | 0.040 |
Why?
|
Adamantane | 1 | 2019 | 173 | 0.040 |
Why?
|
Electrodiagnosis | 1 | 2018 | 151 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2022 | 652 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 8324 | 0.040 |
Why?
|
Sodium Chloride | 1 | 2018 | 625 | 0.030 |
Why?
|
Hydroxamic Acids | 1 | 2019 | 494 | 0.030 |
Why?
|
Algorithms | 1 | 2017 | 13881 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2018 | 1105 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 1959 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2023 | 1584 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2021 | 933 | 0.030 |
Why?
|
Housing | 1 | 2019 | 664 | 0.030 |
Why?
|
Fatty Acids | 1 | 2022 | 1809 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 926 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2274 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1681 | 0.030 |
Why?
|
Travel | 1 | 2019 | 788 | 0.030 |
Why?
|
Recovery of Function | 1 | 2022 | 2925 | 0.030 |
Why?
|
Molecular Imaging | 1 | 2019 | 828 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 4751 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15540 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3558 | 0.020 |
Why?
|
Cost of Illness | 1 | 2019 | 1859 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 63114 | 0.020 |
Why?
|
Histones | 1 | 2019 | 2599 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2019 | 2708 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 25043 | 0.020 |
Why?
|
Caregivers | 1 | 2019 | 2094 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 12959 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2737 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9274 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 9959 | 0.020 |
Why?
|
United States | 2 | 2023 | 69872 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2019 | 13033 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7913 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2019 | 5708 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 85781 | 0.010 |
Why?
|
Brain Mapping | 1 | 2018 | 6669 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19905 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13989 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 21746 | 0.010 |
Why?
|
Time Factors | 1 | 2023 | 40075 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 8949 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 77449 | 0.010 |
Why?
|
Concepts
(114)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_